JPS57112372A - 9-amino-1-hydroxyoctahydrobenzo(c)quinolines and derivatives - Google Patents
9-amino-1-hydroxyoctahydrobenzo(c)quinolines and derivativesInfo
- Publication number
- JPS57112372A JPS57112372A JP56117571A JP11757181A JPS57112372A JP S57112372 A JPS57112372 A JP S57112372A JP 56117571 A JP56117571 A JP 56117571A JP 11757181 A JP11757181 A JP 11757181A JP S57112372 A JPS57112372 A JP S57112372A
- Authority
- JP
- Japan
- Prior art keywords
- hydroxyoctahydrobenzo
- quinolines
- derivatives
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
- C07D221/12—Phenanthridines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/173,207 US4309545A (en) | 1980-07-28 | 1980-07-28 | Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS57112372A true JPS57112372A (en) | 1982-07-13 |
Family
ID=22630983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56117571A Pending JPS57112372A (en) | 1980-07-28 | 1981-07-27 | 9-amino-1-hydroxyoctahydrobenzo(c)quinolines and derivatives |
Country Status (29)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4920221A (en) * | 1982-03-16 | 1990-04-24 | Pfizer Inc. | Substituted decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines |
| US4473704A (en) * | 1982-03-16 | 1984-09-25 | Pfizer Inc. | Substituted dodecahydrotriphenylenes, decahydro-1H-cyclopenta[1]phenanthrenes, decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines as CNS agents |
| US4642373A (en) * | 1982-03-16 | 1987-02-10 | Pfizer Inc. | Substituted dodecahydrotripheylenes, and decahydropyrrolo[1,2-f]phenanthridines as CNS agents |
| US5605906A (en) * | 1995-03-24 | 1997-02-25 | Merck Frosst Canada, Inc. | Cannabinoid receptor agonists |
| EE03523B1 (et) * | 1996-01-31 | 2001-10-15 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine |
| ATE224386T1 (de) * | 1996-03-26 | 2002-10-15 | Altana Pharma Ag | Neue in 6-position substituierte phenanthridine |
| US6127378A (en) * | 1996-03-26 | 2000-10-03 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phenanthridines substituted in the 6 position |
| US5776482A (en) * | 1996-03-29 | 1998-07-07 | University Of Iowa Research Foundation | Tetrahydroquinoline analogues for use in glaucoma treatment |
| PT1000035E (pt) * | 1997-07-25 | 2003-04-30 | Altana Pharma Ag | 6-fenilfenantridinas substituidas |
| ATE224372T1 (de) * | 1997-07-25 | 2002-10-15 | Altana Pharma Ag | Substituierte 6-alkylphenanthridine |
| BR0009200A (pt) | 1999-03-22 | 2001-12-26 | Immugen Pharmaceuticals Inc | Compostos e composições para o tratamento dedoenças associada com disfunção imune |
| US6566560B2 (en) | 1999-03-22 | 2003-05-20 | Immugen Pharmaceuticals, Inc. | Resorcinolic compounds |
| US20060084021A1 (en) * | 2004-09-10 | 2006-04-20 | Kubicek Chris A | Wick holder |
| AU2001296402A1 (en) * | 2000-09-28 | 2002-04-08 | Immugen Pharmaceuticals, Inc. | Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation |
| AU2002213429A1 (en) * | 2000-09-28 | 2002-04-08 | Immugen Pharmaceuticals, Inc. | Antiviral methods and compounds |
| AU2003214226A1 (en) * | 2002-03-18 | 2003-10-08 | Immugen Pharmaceuticals, Inc. | Topical formulations of resorcinols and cannibinoids and methods of use |
| NZ551379A (en) * | 2004-05-25 | 2010-11-26 | Othera Holding Inc | Oculoselective drugs and prodrugs |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS52144672A (en) * | 1976-05-17 | 1977-12-02 | Pfizer | Novel benzo *c* quinolines |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3839441A (en) * | 1969-10-27 | 1974-10-01 | Hoffmann La Roche | Intermediates for partially hydrogenated phenanthridines |
| US3878219A (en) * | 1973-07-13 | 1975-04-15 | Abbott Lab | 5H-{8 1{9 benzopyrano{8 3,4-d{9 pyridines |
| US3928598A (en) * | 1973-11-05 | 1975-12-23 | Lilly Co Eli | Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug |
| US4087545A (en) * | 1976-02-17 | 1978-05-02 | Eli Lilly And Company | Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs |
| HU180916B (hu) | 1976-05-17 | 1983-05-30 | Pfizer | Eljárás benzo[c]kinolin-származékok előállítására |
| US4152450A (en) * | 1978-02-17 | 1979-05-01 | Eli Lilly And Company | 9-Amino-dibenzopyrans |
-
1980
- 1980-07-28 US US06/173,207 patent/US4309545A/en not_active Expired - Lifetime
-
1981
- 1981-07-03 IN IN429/DEL/81A patent/IN158867B/en unknown
- 1981-07-21 GT GT198170557A patent/GT198170557A/es unknown
- 1981-07-21 DE DE8181303339T patent/DE3168891D1/de not_active Expired
- 1981-07-21 EP EP81303339A patent/EP0045171B1/en not_active Expired
- 1981-07-21 AT AT81303339T patent/ATE11775T1/de not_active IP Right Cessation
- 1981-07-22 SU SU813317052A patent/SU1217254A3/ru active
- 1981-07-22 HU HU812141A patent/HU185133B/hu not_active IP Right Cessation
- 1981-07-23 CS CS815647A patent/CS228515B2/cs unknown
- 1981-07-23 PL PL1981232331A patent/PL133928B1/pl unknown
- 1981-07-24 CA CA000382558A patent/CA1178274A/en not_active Expired
- 1981-07-24 GR GR65624A patent/GR75283B/el unknown
- 1981-07-24 AR AR286204A patent/AR230988A1/es active
- 1981-07-24 IE IE1686/81A patent/IE51426B1/en unknown
- 1981-07-24 DD DD81232067A patent/DD202012A5/de unknown
- 1981-07-27 NO NO812557A patent/NO812557L/no unknown
- 1981-07-27 PH PH25968A patent/PH17281A/en unknown
- 1981-07-27 ES ES504323A patent/ES8301926A1/es not_active Expired
- 1981-07-27 IL IL63423A patent/IL63423A0/xx unknown
- 1981-07-27 DK DK334581A patent/DK334581A/da not_active Application Discontinuation
- 1981-07-27 KR KR1019810002717A patent/KR850000273B1/ko not_active Expired
- 1981-07-27 AU AU73434/81A patent/AU525944B2/en not_active Ceased
- 1981-07-27 NZ NZ197856A patent/NZ197856A/en unknown
- 1981-07-27 FI FI812338A patent/FI812338A7/fi not_active Application Discontinuation
- 1981-07-27 YU YU01851/81A patent/YU185181A/xx unknown
- 1981-07-27 EG EG431/81A patent/EG15535A/xx active
- 1981-07-27 JP JP56117571A patent/JPS57112372A/ja active Pending
- 1981-07-27 ZA ZA815128A patent/ZA815128B/xx unknown
- 1981-07-28 PT PT73440A patent/PT73440B/pt not_active IP Right Cessation
-
1985
- 1985-11-08 NO NO854454A patent/NO854454L/no unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS52144672A (en) * | 1976-05-17 | 1977-12-02 | Pfizer | Novel benzo *c* quinolines |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT73995B (en) | Thiadiazinone oxadiazinone and triazinone derivatives | |
| GB2094789B (en) | Carbostyril derivatives | |
| DE3168891D1 (en) | 9-amino-1-hydroxyoctahydrobenzo(c)quinolines and derivatives thereof | |
| DE3262122D1 (en) | Quinoline derivatives | |
| GB2089348B (en) | Benzopyran and benzothiapyran derivatives | |
| GB2108109B (en) | Carbostyril derivatives | |
| GB2070016B (en) | 17-acyloxy-5-corticoids and 17-acyloxy-5-corticoids | |
| DE3377796D1 (en) | Quinoline derivatives | |
| GB2070588B (en) | Carbostyril derivatives | |
| IL64774A (en) | Hexahydro-trans and tetrahydropyridoindole derivatives | |
| PH16940A (en) | Substituted phenoxy-aminopropanol derivatives and medicaments thereof | |
| DE3266355D1 (en) | Octahydrotetracyanoquinodimethane and derivatives thereof | |
| DE3162888D1 (en) | Cyclic acylaminoperfluoroalkanesulfonanilides and derivatives thereof | |
| GB2124628B (en) | 6-oxo-tetrahydropyran derivatives and cyanomethyl-azetidinones | |
| ZW17881A1 (en) | Heteroprostaglandin derivatives and processes for preparing them | |
| GB2090829B (en) | 16-amino-pgf2 and derivatives | |
| GB2082176B (en) | Heteroprostaglandin derivatives and processes for preparing them | |
| ZA814947B (en) | Heteroprostaglandin derivatives and processes for preparing them | |
| EG14215A (en) | Substituted-4-alkylthioalkanesulfonanilides and derivatives thereof | |
| DE3162812D1 (en) | Acyclicacylaminoperfluoroalkanesulfonanilides and derivatives thereof | |
| EG14831A (en) | 4-phenylthioalkanesulfonanilides and derivatives thereof | |
| AU545825B2 (en) | Biphenylmethanols and derivatives thereof | |
| IL72957A0 (en) | 9-oximino-1-hydroxyhexahydrobenzo(c)quinoline derivatives | |
| IE802488L (en) | Quinoline derivatives | |
| IE802256L (en) | Quinolines |